Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TriPath Withdraws Its Second PMA Supplement Application This Year

This article was originally published in The Gray Sheet

Executive Summary

TriPath Imaging has been reorganizing its clinical and regulatory affairs operations to prevent the continuation of problems that caused it to withdraw two separate PMA supplements so far this year

You may also be interested in...



BD’s TriPath Imaging Buyout Would Integrate Cancer Diagnostics Partner

Becton Dickinson will gain TriPath Imaging's SurePath liquid-based Pap test and fledgling molecular oncology diagnostics business should its $350 mil. acquisition offer be accepted

BD’s TriPath Imaging Buyout Would Integrate Cancer Diagnostics Partner

Becton Dickinson will gain TriPath Imaging's SurePath liquid-based Pap test and fledgling molecular oncology diagnostics business should its $350 mil. acquisition offer be accepted

TriPath Imaging Ramps Up Regulatory And Clinical Spending In 2006

TriPath Imaging will increase investment in its regulatory and clinical affairs programs by $6.5 mil.-$7 mil. in 2006 to support FDA approval of its breast cancer staging assay, SurePath molecular Pap test and FocalPoint GS imaging system

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel